Role of MRD in elderly acute myeloid leukemia | CIA
The Role of Measurable Residual Disease in AML (Transcript)
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party - ScienceDirect
Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML) | FNIH
Frontiers | MRD Tailored Therapy in AML: What We Have Learned So Far
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia - Biology of Blood and Marrow Transplantation
Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients | Haematologica
MRD Tailored Therapy in AML: What We Have Learned So Far. - Abstract - Europe PMC
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia | Leukemia
Minimal Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia | IntechOpen
a Minimal residual disease (MRD) in acute myeloid leukemia (AML) using... | Download Scientific Diagram
Cancers | Free Full-Text | Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges
IJMS | Free Full-Text | Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication
MRD assessment in different therapeutic stadia of AML. | Download Scientific Diagram
Frontiers | MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party - ScienceDirect
AML-4: Using big data to confirm the link between MRD and survival in AML - HARMONY Alliance
Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
MRD evaluation during treatment of AML patients according to ELN... | Download Scientific Diagram
MRD in AML: Prognosis, treatment, and surrogate endpoints
Monitoring of minimal residual disease in acute myeloid leukemia
How Is Minimal Residual Disease (MRD) Monitored in Leukemia? | MyLeukemiaTeam
MRD in AML: The Role of New Techniques | Semantic Scholar
Clinical implications of measurable residual disease in AML: Review of current evidence - ScienceDirect
What Is the Measure of Minimal Residual Disease in AML - The ASCO Post
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML - ScienceDirect
